19th Pharmacovigilance 2021

  • 2021 (Not Final)
  • Location is not final

19th Pharmacovigilance 2021 covers topics such as:

  • Updates towards of legislation, policies, systems, technology, communication strategies and best practice in PV
  • Establishing and streamlining pharmacovigilance in the US: where are we heading?
  • Why does pharmacovigilance sometimes fail and where
could the fault lie?
  • Analyzing the Challenges and Opportunities to optimize the overall PV ecosystem
  • Postmarketing safety monitoring within OSE
  • Updates from the Office of Surveillance and Epidemiology (OSE) within CDER.
  • Revised GVP guidance on signal management – how to implement?
  • Pharmacovigilance and healthcare system
  • Review the various data sources available in post-marketing setting and their pros & cons
  • Updates to PSUR, PBRERs, DSUR, PASS
  • Future of outsourced phase I, II and III trials and post-marketing studies, inc. pharmacovigilance
  • Good Clinical Practices and Good Pharmacovigilance practices
  • Strategies to improve clinical trials and PV
  • Emerging technologies to efficiently collect, store and analyze data in a comprehensive data management system
  • Patient centric approach to help improve patient safety
  • Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
  • PV Audit & inspections - preparation, implementation and lessons to be learnt
  • Outsourcing activities - How to set it right?
  • Outsourcing Vs In-House
  • Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
  • Current regulations and guidelines - USA and EU PV
  • The effect of Brexit on Pharmacovigilance
  • Accelerating new medicine introduction in developing world & overcoming challenges
  • The developing regulatory framework in advanced and developing markets

19th Pharmacovigilance 2021 brings together Vice Presidents, Directors, CRO’s, Heads and Managers of:

  • Drug Safety/Risk Management
  • Pharmacovigilance Strategy
  • Clinical Research
  • Information and Clinical Data Management
  • Product Safety/Assurance Assessment
  • Research & Development
  • Epidemiology project management
  • Patient Safety & Outcomes Research & Data Analysis
  • Sales & Marketing
  • Regulatory Affairs and Compliance
  • Biotech manufacturers

from:

  • Generic pharmaceutical companies
  • Pharmaceutical organizations
  • Patient recruitment companies
  • Contract research organizations
  • Non-profit organizations/ Association
  • Government- Department of health
  • Consultants

19th Pharmacovigilance 2021 might be held in 2021 (Not Final).

10000-15000 Indian Rupee
Included
Virtue Insight
Rentalcars Savings

Past and Future Events

  • 20th Pharmacovigilance 2021 - 2021 (42140)
  • 19th Pharmacovigilance 2021 - 2021 (32365)
  • 18th Pharmacovigilance 2019 - 27-28 Feb 2019, London, United Kingdom (34822)
  • 17th Pharmacovigilance 2018 - 15 Nov 2018, Mumbai, India (72849)
  • 16th Pharmacovigilance 2018 - 2-4 Oct 2018, Boston, United States (72848)
  • 15th Pharmacovigilance 2018 - 21-22 Feb 2018, London, United Kingdom (53651)
  • 14th Pharmacovigilance 2017 - 9 Nov 2017, Mumbai, India (70251)
  • 13th Pharmacovigilance 2017 - 27-28 Sep 2017, Chicago, United States (47486)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Other Events with Similar Location or Organizer